Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310773899> ?p ?o ?g. }
- W4310773899 endingPage "26.e8" @default.
- W4310773899 startingPage "18" @default.
- W4310773899 abstract "To analyze, in a cohort of pediatric patients with recurrent pericarditis undergoing anti-interleukin (IL)-1 treatment: the agent and dosing used as first-line treatment, the long-term efficacy of IL-1 blockers, the percentage of patients achieving a drug-free remission, and the presence of variables associated with drug-free remission.Data were collected from patients' charts. The annualized relapse rate (ARR) was used for evaluation of treatment efficacy, and bivariate logistic regression analysis was used for variables associated with drug-free remission.Fifty-eight patients, treated between 2008 and 2018, were included in the study (mean follow-up. 2.6 years). Of the 56 patients treated with first-line drugs, 14 not responsive patients were underdosed. Fifty-seven patients were treated with anakinra: the ARR before and during daily treatment was 3.05 and 0.28, respectively (P < .0001); an increase to 0.83 was observed after the reduction/withdrawal of treatment (P < .0001). The switch from anakinra to canakinumab (5 patients) was associated to an increase of the ARR (0.49 vs 1.46), but without statistical significance (P = .215). At last follow-up, only 9 of the 58 patients had withdrawn all treatments. With the limits of a retrospective study and the heterogeneity between the patients enrolled in the study, a shorter duration of treatment with anakinra was the only variable associated with drug-free remission.This study shows that most pediatric patients with recurrent pericarditis needing IL-1 blockade received an inadequate treatment with first-line agents. The effectiveness of anakinra is supported by this study, but few patients achieved drug-free remission. The different rate of response to anakinra and canakinumab may suggest a possible role of IL-1α in the pathogenesis of recurrent pericarditis." @default.
- W4310773899 created "2022-12-17" @default.
- W4310773899 creator A5001209743 @default.
- W4310773899 creator A5001567119 @default.
- W4310773899 creator A5003157677 @default.
- W4310773899 creator A5008034089 @default.
- W4310773899 creator A5008715238 @default.
- W4310773899 creator A5010865922 @default.
- W4310773899 creator A5014566743 @default.
- W4310773899 creator A5015250537 @default.
- W4310773899 creator A5024987917 @default.
- W4310773899 creator A5030743413 @default.
- W4310773899 creator A5035736675 @default.
- W4310773899 creator A5036785123 @default.
- W4310773899 creator A5039616289 @default.
- W4310773899 creator A5043887994 @default.
- W4310773899 creator A5045090353 @default.
- W4310773899 creator A5046206108 @default.
- W4310773899 creator A5050408497 @default.
- W4310773899 creator A5050782259 @default.
- W4310773899 creator A5054792352 @default.
- W4310773899 creator A5063656963 @default.
- W4310773899 creator A5065247060 @default.
- W4310773899 creator A5067354798 @default.
- W4310773899 creator A5070213960 @default.
- W4310773899 creator A5071379577 @default.
- W4310773899 creator A5076511221 @default.
- W4310773899 creator A5076793208 @default.
- W4310773899 creator A5076916358 @default.
- W4310773899 creator A5078129761 @default.
- W4310773899 creator A5084887506 @default.
- W4310773899 creator A5089311635 @default.
- W4310773899 date "2023-05-01" @default.
- W4310773899 modified "2023-09-23" @default.
- W4310773899 title "Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 Blockade" @default.
- W4310773899 cites W1995437293 @default.
- W4310773899 cites W2028561409 @default.
- W4310773899 cites W2062428590 @default.
- W4310773899 cites W2104933371 @default.
- W4310773899 cites W2129554354 @default.
- W4310773899 cites W2132960346 @default.
- W4310773899 cites W2150915427 @default.
- W4310773899 cites W2195401421 @default.
- W4310773899 cites W2478828086 @default.
- W4310773899 cites W2498839525 @default.
- W4310773899 cites W2551094451 @default.
- W4310773899 cites W2613233208 @default.
- W4310773899 cites W2928947990 @default.
- W4310773899 cites W2940679238 @default.
- W4310773899 cites W2981072868 @default.
- W4310773899 cites W3034515329 @default.
- W4310773899 doi "https://doi.org/10.1016/j.jpeds.2022.11.034" @default.
- W4310773899 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36470465" @default.
- W4310773899 hasPublicationYear "2023" @default.
- W4310773899 type Work @default.
- W4310773899 citedByCount "0" @default.
- W4310773899 crossrefType "journal-article" @default.
- W4310773899 hasAuthorship W4310773899A5001209743 @default.
- W4310773899 hasAuthorship W4310773899A5001567119 @default.
- W4310773899 hasAuthorship W4310773899A5003157677 @default.
- W4310773899 hasAuthorship W4310773899A5008034089 @default.
- W4310773899 hasAuthorship W4310773899A5008715238 @default.
- W4310773899 hasAuthorship W4310773899A5010865922 @default.
- W4310773899 hasAuthorship W4310773899A5014566743 @default.
- W4310773899 hasAuthorship W4310773899A5015250537 @default.
- W4310773899 hasAuthorship W4310773899A5024987917 @default.
- W4310773899 hasAuthorship W4310773899A5030743413 @default.
- W4310773899 hasAuthorship W4310773899A5035736675 @default.
- W4310773899 hasAuthorship W4310773899A5036785123 @default.
- W4310773899 hasAuthorship W4310773899A5039616289 @default.
- W4310773899 hasAuthorship W4310773899A5043887994 @default.
- W4310773899 hasAuthorship W4310773899A5045090353 @default.
- W4310773899 hasAuthorship W4310773899A5046206108 @default.
- W4310773899 hasAuthorship W4310773899A5050408497 @default.
- W4310773899 hasAuthorship W4310773899A5050782259 @default.
- W4310773899 hasAuthorship W4310773899A5054792352 @default.
- W4310773899 hasAuthorship W4310773899A5063656963 @default.
- W4310773899 hasAuthorship W4310773899A5065247060 @default.
- W4310773899 hasAuthorship W4310773899A5067354798 @default.
- W4310773899 hasAuthorship W4310773899A5070213960 @default.
- W4310773899 hasAuthorship W4310773899A5071379577 @default.
- W4310773899 hasAuthorship W4310773899A5076511221 @default.
- W4310773899 hasAuthorship W4310773899A5076793208 @default.
- W4310773899 hasAuthorship W4310773899A5076916358 @default.
- W4310773899 hasAuthorship W4310773899A5078129761 @default.
- W4310773899 hasAuthorship W4310773899A5084887506 @default.
- W4310773899 hasAuthorship W4310773899A5089311635 @default.
- W4310773899 hasBestOaLocation W43107738992 @default.
- W4310773899 hasConcept C126322002 @default.
- W4310773899 hasConcept C141071460 @default.
- W4310773899 hasConcept C151956035 @default.
- W4310773899 hasConcept C167135981 @default.
- W4310773899 hasConcept C2777288759 @default.
- W4310773899 hasConcept C2779134260 @default.
- W4310773899 hasConcept C2781228260 @default.
- W4310773899 hasConcept C65409693 @default.
- W4310773899 hasConcept C71924100 @default.
- W4310773899 hasConcept C72563966 @default.